Mevalonate pathway inhibitors in the treatment of B-cell chronic lymphocytic leukemia.

6561 Background: B-cell chronic lymphocytic leukemia (CLL) cells are arrested in G0/G1 phase of the cell cycle and are resistant to programmed cell death, hypothesized to contribute to the resistan...